Protocol No.: GN41791

A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Patients with Primary Progressive Multiple Sclerosis
Principal Investigator
Ward, Melanie
Phase
III
Age Group
Adult
Applicable Disease Site
Neurology
Participating Institutions
Health Sciences Center
West Virginia University
Contact
Lauren Chase, RN
Clinical Research Specialist
Phone: +1 304-598-4000

View on ClinicalTrials.gov